Literature DB >> 14672608

Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor.

Anna Strömsten1, Sara von Bahr, Sven Bringman, Masayumi Saeki, Staffan Sahlin, Ingemar Björkhem, Curt Einarsson.   

Abstract

BACKGROUND/AIMS: Cholesterolosis is characterized by accumulation of esterified cholesterol in human gallbladder mucosa. The present study aimed at investigating possible pathogenetic factors for cholesterolosis. The hypothesis was tested that a reduced sterol 27-hydroxylase or an increased amount of ACAT-1 enzyme may be of importance.
METHODS: Gall bladder mucosa and bile were obtained from patients with cholesterol gallstones undergoing cholecystectomy (30 with and 43 without cholesterolosis).
RESULTS: In cholesterolosis, the gall bladder mucosa was characterized by a several-fold increase in esterified cholesterol and normal content of free cholesterol. The amount of ACAT-1 protein, measured by immunoblotting, was similar in patients with and without cholesterolosis. The level of 27-hydroxycholesterol in gallbladder mucosa was elevated sevenfold as compared with cholesterol in patients with cholesterolosis. Most (87%) of this oxysterol was esterified and the accumulation is most probably secondary to the higher total amount of cholesterol in the cells. Patients with cholesterolosis had normal levels of both sterol 27-hydroxylase mRNA (real time polymerase chain reaction) and protein (immunoblotting). The enzymatic activity of the sterol 27-hydroxylase in gallbladder mucosa was normal or increased in cholesterolosis.
CONCLUSIONS: The pathogenesis of cholesterolosis may be multifactorial, but is not caused by reduced efflux of cholesterol due to a defect sterol 27-hydroxylase mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14672608     DOI: 10.1016/s0168-8278(03)00502-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Expression profiling suggests a regulatory role of gallbladder in lipid homeostasis.

Authors:  Zuo-Biao Yuan; Tian-Quan Han; Zhao-Yan Jiang; Jian Fei; Yi Zhang; Jian Qin; Zhi-Jie Tian; Jun Shang; Zhi-Hong Jiang; Xing-Xing Cai; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Analysis of risk factors for polypoid lesions of gallbladder among health examinees.

Authors:  Hua-Li Yang; Lei Kong; Li-Li Hou; Hui-Fang Shen; Yu Wang; Xin-Gang Gu; Jian-Min Qin; Pei-Hao Yin; Qi Li
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

3.  Pioglitazone reduces lipid droplets in cholesterolosis of the gallbladder by increasing ABCA1 and NCEH1 expression.

Authors:  Jing-Min Wang; Dong Wang; Yu-Yan Tan; Gang Zhao; Zhen-Ling Ji
Journal:  Mol Cell Biochem       Date:  2014-10-04       Impact factor: 3.396

4.  Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study.

Authors:  Xiaofang Zhao; Huabo Zheng; Shengshuai Shan; Kun Wang; Meng Zhang; Songpu Xie; Chengyun Liu
Journal:  Lipids Health Dis       Date:  2020-06-23       Impact factor: 3.876

5.  Risk factors for gallbladder polyps observed through second-look abdominal sonography in patients with fatty liver disease.

Authors:  Shu-Hsien Lin; Kun-Ta Wu; Yi-Chun Chiu; Chih-Chi Wang; King-Wah Chiu
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.